Component

Mouse cysteine dioxygenase / Cdo1

Context-specific entity; species, compartment and exposure are stated on each claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Liver-specific Cdo1 deletion increased extrahepatic CDO abundance and hypotaurine; mice maintained taurine, glutathione and sulfate despite a taurine-free diet.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Conditional mouse liver knockout; kidney, adipose and pancreatic measurements.
    limitations
    This tissue-restricted deletion differs from complete pathway loss and from human deficiency.
    nutrient_topic
    Taurine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Taurine
    plain_language
    Other tissues compensated when liver synthesis was impaired.
    primary_references
    Extrahepatic tissues compensate for loss of hepatic taurine synthesis in mice with liver-specific knockout of cysteine dioxygenase. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22414809/ · DOI 10.1152/ajpendo.00589.2011

    Taurine: synthesis, transport, mitochondrial decoding and nutrient interactions (2026-09-19) · lines 97–103

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Conditional mouse liver knockout; kidney, adipose and pancreatic measurements. · source_derived_draft · unverified_draft

    ## taurine-hepatic-compensation Other tissues compensated when liver synthesis was impaired. Liver-specific Cdo1 deletion increased extrahepatic CDO abundance and hypotaurine; mice maintained taurine, glutathione and sulfate despite a taurine-free diet. Model: Conditional mouse liver knockout; kidney, adipose and pancreatic measurements. Limitations: This tissue-restricted deletion differs from complete pathway loss and from human deficiency. Evidence access: Primary abstract Extrahepatic tissues compensate for loss of hepatic taurine synthesis in mice with liver-specific knockout of cysteine dioxygenase. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22414809/ · DOI 10.1152/ajpendo.00589.2011
    Complete structured claim and evidence
  2. Deleting Cdo1 in mouse mesenchymal/osteolineage cells reduced support for leukemia growth and prolonged survival in the transplanted leukemia model.

    Experimental context and source evidence
    evidence_access
    Primary full text, Figure 2 and niche experiments
    experimental_model
    Conditional mouse Cdo1 deletion, coculture and leukemia transplantation.
    limitations
    An established leukemia model does not measure cancer incidence in healthy supplement users.
    nutrient_topic
    Taurine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Taurine
    plain_language
    The tumor-supporting tissue supplied taurine to leukemia cells.
    primary_references
    Taurine from tumour niche drives glycolysis to promote leukaemogenesis. · 2025 · https://pubmed.ncbi.nlm.nih.gov/40369079/ · DOI 10.1038/s41586-025-09018-7

    Taurine: synthesis, transport, mitochondrial decoding and nutrient interactions (2026-09-19) · lines 513–519

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Conditional mouse Cdo1 deletion, coculture and leukemia transplantation. · source_derived_draft · unverified_draft

    ## taurine-niche-mouse-cdo1 The tumor-supporting tissue supplied taurine to leukemia cells. Deleting Cdo1 in mouse mesenchymal/osteolineage cells reduced support for leukemia growth and prolonged survival in the transplanted leukemia model. Model: Conditional mouse Cdo1 deletion, coculture and leukemia transplantation. Limitations: An established leukemia model does not measure cancer incidence in healthy supplement users. Evidence access: Primary full text, Figure 2 and niche experiments Taurine from tumour niche drives glycolysis to promote leukaemogenesis. · 2025 · https://pubmed.ncbi.nlm.nih.gov/40369079/ · DOI 10.1038/s41586-025-09018-7
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards